PAG
IBB icon

Private Advisor Group’s iShares Biotechnology ETF IBB Stock Holding History

Private Advisor Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.49M Sell
23,602
-3,598
-13% -$618K 0.02% 670
2026
Q1 		$4.59M Buy
27,200
+800
+3% +$137K 0.02% 682
2025
Q4 		$4.46M Sell
26,400
-4,340
-14% -$705K 0.02% 666
2025
Q3 		$4.44M Buy
30,740
+6,160
+25% +$841K 0.02% 672
2025
Q2 		$3.11M Sell
24,580
-2,981
-11% -$366K 0.02% 764
2025
Q1 		$3.53M Sell
27,561
-1,234
-4% -$167K 0.02% 653
2024
Q4 		$3.81M Sell
28,795
-3,299
-10% -$464K 0.02% 620
2024
Q3 		$4.67M Sell
32,094
-1,213
-4% -$176K 0.03% 559
2024
Q2 		$4.57M Sell
33,307
-4,929
-13% -$658K 0.03% 521
2024
Q1 		$5.25M Sell
38,236
-5,753
-13% -$786K 0.04% 443
2023
Q4 		$5.98M Sell
43,989
-6,668
-13% -$814K 0.05% 370
2023
Q3 		$6.17M Buy
50,657
+2,294
+5% +$292K 0.06% 329
2023
Q2 		$6.16M Buy
48,363
+1,683
+4% +$219K 0.05% 338
2023
Q1 		$6.03M Sell
46,680
-545
-1% -$71.3K 0.06% 336
2022
Q4 		$667K Buy
47,225
+6,895
+17% +$891K 0.03% 479
2022
Q3 		$4.72M Sell
40,330
-2,179
-5% -$271K 0.05% 354
2022
Q2 		$5M Sell
42,509
-2,054
-5% -$244K 0.04% 407
2022
Q1 		$5.81M Sell
44,563
-2,684
-6% -$350K 0.04% 395
2021
Q4 		$7.21M Buy
47,247
+1,360
+3% +$211K 0.05% 341
2021
Q3 		$7.42M Buy
45,887
+6,660
+17% +$1.12M 0.05% 385
2021
Q2 		$6.42M Sell
39,227
-160
-0.4% -$24.6K 0.06% 327
2021
Q1 		$5.93M Buy
39,387
+499
+1% +$79.3K 0.06% 332
2020
Q4 		$5.89M Sell
38,888
-27,300
-41% -$3.9M 0.06% 298
2020
Q3 		$9M Buy
66,188
+2,487
+4% +$337K 0.12% 184
2020
Q2 		$8.71M Buy
63,701
+18,224
+40% +$2.32M 0.12% 179
2020
Q1 		$4.9M Buy
45,477
+9,411
+26% +$1.08M 0.09% 230
2019
Q4 		$4.35M Sell
36,066
-54,463
-60% -$6.08M 0.07% 296
2019
Q3 		$9.01M Sell
90,529
-3,534
-4% -$370K 0.14% 166
2019
Q2 		$10.3M Sell
94,063
-7,909
-8% -$841K 0.19% 121
2019
Q1 		$11.4M Buy
101,972
+11,554
+13% +$1.27M 0.23% 99
2018
Q4 		$8.72M Buy
90,418
+51,001
+129% +$5.41M 0.21% 109
2018
Q3 		$4.81M Buy
39,417
+23,885
+154% +$2.81M 0.1% 212
2018
Q2 		$1.72M Sell
15,532
-17,099
-52% -$1.83M 0.03% 328
2018
Q1 		$3.48M Buy
32,631
+12,410
+61% +$1.38M 0.14% 162
2017
Q4 		$2.19M Sell
20,221
-35,048
-63% -$3.75M 0.09% 223
2017
Q3 		$6.25M Sell
55,269
-7,164
-11% -$766K 0.15% 146
2017
Q2 		$6.45M Buy
62,433
+22,323
+56% +$2.2M 0.17% 135
2017
Q1 		$3.84M Sell
40,110
-13,920
-26% -$1.33M 0.11% 199
2016
Q4 		$5.01M Buy
54,030
+14,013
+35% +$1.28M 0.16% 134
2016
Q3 		$3.85M Buy
40,017
+11,508
+40% +$1.09M 0.16% 137
2016
Q2 		$2.53M Buy
28,509
+2,226
+8% +$200K 0.1% 202
2016
Q1 		$2.29M Sell
26,283
-14,985
-36% -$1.34M 0.11% 189
2015
Q4 		$4.65M Buy
41,268
+14,898
+56% +$1.62M 0.22% 98
2015
Q3 		$2.67M Buy
26,370
+5,001
+23% +$600K 0.15% 146
2015
Q2 		$2.63M Buy
21,369
+5,088
+31% +$609K 0.12% 166
2015
Q1 		$1.86M Buy
16,281
+3,969
+32% +$438K 0.11% 222
2014
Q4 		$1.25M Sell
12,312
-351
-3% -$34.1K 0.08% 293
2014
Q3 		$1.16M Sell
12,663
-4,692
-27% -$412K 0.08% 278
2014
Q2 		$1.49M Sell
17,355
-3,708
-18% -$292K 0.13% 182
2014
Q1 		$1.66M Sell
21,063
-78
-0.4% -$6.5K 0.18% 137
2013
Q4 		$1.6M Buy
+21,141
New +$1.5M 0.18% 133

Other funds holding IBB

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

Private Advisor Group's IBB Position: Q2 2026 in Review

Private Advisor Group reduced its iShares Biotechnology ETF (IBB) stake by 13% in Q2 2026, selling an estimated $618K and leaving 23,602 shares worth $4.49M. The position accounts for 0.02% of the portfolio, ranked #670.

Private Advisor Group first reported a position in IBB in Q4 2013 and has held it in 51 quarters since. The position peaked at $11.4M in Q1 2019. 399 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Private Advisor Group held 23,602 shares of iShares Biotechnology ETF worth $4.49M as of Q2 2026.
  • Private Advisor Group sold 3,598 iShares Biotechnology ETF shares in Q2 2026, an estimated $618K.
  • iShares Biotechnology ETF made up 0.02% of Private Advisor Group's portfolio in Q2 2026, its #670 holding.
  • Private Advisor Group first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 51 quarters since.
  • Private Advisor Group's iShares Biotechnology ETF position peaked at $11.4M in Q1 2019.
  • 399 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.